American Health & Drug Benefits^® examines drug and other healthcare intervention value from the separate and unified vantage points of each stakeholder group to the process: payers, purchasers, providers, patients, manufacturers, regulators, distributors, and evaluators. Directly or indirectly, all parties to healthcare benefits influence policy and demand satisfaction of their interests.

Targeted circulation showcasing the multidisciplinary nature of health & drug benefits decision makers.

Total Circulation: 30,000

New Rules of Engagement

MISSION STATEMENT
American Health & Drug Benefits (AHDB) is an independent, peer-reviewed journal founded in 2008 on the concept that health and drug benefits have undergone a transformation: the econometric value of a therapy is currently of equal importance to clinical outcomes as it is to serving as the basis for coverage decisions and benefit designs. Because benefit designs are greatly affected by clinical, business, and policy conditions, the journal offers a forum for stakeholder integration and collaboration toward the promotion of value-based healthcare. AHDB further provides benefit design makers the integrated information they need to devise benefit designs and make coverage decisions that stand up to today’s special healthcare delivery and business needs.

NEWS AND ANNOUNCEMENTS

• Introducing THE LYNX GROUP™: A Global, Strategic Alliance Providing Pivotal and Contemporary Medical Information and Education for All Stakeholders in Healthcare